Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.
This is a prospective, multi-center, registry to enroll patients undergoing DCB treatment. All subjects undergoing DCB treatment will be enrolled in this study without strict inclusion and exclusion criteria. Data and images will be collected during the index procedure, and at the clinical and angiographic follow-up.
Study Type
OBSERVATIONAL
Enrollment
3,000
DCB (Sequent® Please) treatment for CAD patients will be enrolled. Intravascular ultrasound (Boston Scientific®) guidance is recommended.
Nanjing First Hospital
Nanjing, Jiangsu, China
RECRUITINGtarget vessel failure (TVF) at 12 months
TVF is defined as the composite of cardiac death, target-vessel myocardial infarction and ischemia-driven target- vessel revascularization.
Time frame: 12 months
Parameter by quantitative coronary angiography at 7 months
Late lumen loss
Time frame: 7 months
Bleeding at 12 months
bleeding
Time frame: 12 months
Bailout drug-eluting stents (DES) implantation rate
Bailout DES implantation rate during procedure by angiographic criteria
Time frame: During procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.